NCT01725243View on ClinicalTrials.gov

Carbetocin at Cesarean Delivery for Labor Arrest

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2013

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Carbetocin

Carbetocin IV, over 1 minute following delivery. Doses: 10, 20, 40, 60, 80, 100, 120 or 140mcg

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT01725243 - Carbetocin at Cesarean Delivery for Labor Arrest | Biotech Hunter | Biotech Hunter